Éric Rullier

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial

Thierry Conroy, Jean-François Bosset, Pierre-Luc Etienne et al. · The Lancet Oncology · 2021 · 1.3K citations

Medicine, Oncology, Surgery +17

Risk factors for anastomotic leakage after resection of rectal cancer

Éric Rullier, J L Garrelon, Pierre Michel et al. · British journal of surgery · 1998 · 904 citations

Medicine, Oncology, Surgery +15

Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6)

Jérémie H. Lefèvre, Laurent Mineur, Salma Kotti et al. · Journal of Clinical Oncology · 2016 · 472 citations

Medicine, Oncology, Surgery +17

Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial

Éric Rullier, Philippe Rouanet, Jean‐Jacques Tuech et al. · The Lancet · 2017 · 378 citations

Medicine, Oncology, Surgery +17

Sphincter-Saving Resection for All Rectal Carcinomas

Éric Rullier, F. Bretagnol, Anne Rullier et al. · Annals of Surgery · 2005 · 367 citations · Full text

Medicine, Oncology, Surgery +17